Eli Lilly’s COVID-19 therapy development partner AbCellera raises $105 million

Eli Lilly’s COVID-19 therapy development partner AbCellera raises $105 million

When AbCellera won a $30 million contract with the Defense Advanced Research Projects Agency to develop therapeutic countermeasures against viral outbreaks two years ago, it’s safe to assume that no …
Read More

Leave a Reply